Dong Zhang
Xiaoxita, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and Efficacy of Obicetrapib in Patients at High Cardiovascular Risk.
Journal: The New England journal of medicine
Published: September 03, 2025
Dynamic glycemic monitoring and systemic inflammation assessment: New insights into plaque characteristics in acute myocardial infarction.
Journal: International journal of cardiology
Published: February 25, 2025
Lysosomal homeostasis regulates myocardial ischemia-reperfusion injury through autophagy pathway.
Journal: Scientific reports
Published: February 25, 2025
Targeting XR008038-galectin-3 axis: A promising therapeutic strategy for myocardial ischemia/reperfusion injury.
Journal: International journal of cardiology
Published: February 09, 2025
The link between ferroptosis and autophagy in myocardial ischemia/reperfusion injury: new directions for therapy.
Journal: Journal of cardiovascular translational research
Published: July 04, 2024
Autosis: a new form of cell death in myocardial ischemia-reperfusion injury.
Journal: Molecular and cellular biochemistry
Published: January 19, 2024
Role of M6a Methylation in Myocardial Ischemia-Reperfusion Injury and Doxorubicin-Induced Cardiotoxicity.
Journal: Cardiovascular toxicology
Published: June 30, 2023
cFLIPL alleviates myocardial ischemia-reperfusion injury by regulating pyroptosis.
Journal: Cell biology international
Published: May 20, 2023
Research Progress on Histone Deacetylases Regulating Programmed Cell Death in Atherosclerosis.
Journal: Journal of cardiovascular translational research
Published: May 07, 2023
Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
Journal: International journal of cardiology
Published: January 04, 2023
Liraglutide Attenuates Myocardial Ischemia/Reperfusion Injury Through the Inhibition of Necroptosis by Activating GLP-1R/PI3K/Akt Pathway.
Journal: Cardiovascular toxicology
Published: July 03, 2022
cFLIPL Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress.
cFLIPL Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress.
Journal: Cardiovascular drugs and therapy
Published: October 08, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026